Mydecine Innovations Group’s Director, CEO & Co-Founder, Joshua Bartch chats with our Director of Content, Jill Ettinger.
Mydecine Innovations Group’s Director, CEO & Co-Founder, Joshua Bartch chats with our Director of Content, Jill Ettinger.
In this episode of the Psychedelic Spotlight podcast, we speak with the Co-Founder, CEO and Director of Mydecine Innovations Group, Joshua Bartch. We discuss the company’s novel research protocols, its relationship with legal psilocybin growers in Jamaica, and the future for psychedelic therapy.
*To learn more about the company featured in this episode and the work they’re doing, visit their website: Mydecine.com
MindMed Near Term CATALYSTS & Nasdaq Debrief [MMED / MNMD]
